1
2
R. J. S. D. Heine, F. W. Thielen, R. H. J. Mathijssen, R. W. F. van Leeuwen, M. G. Franken, C. A. Uyl-de Groot
2024
2024
Volltext
Weitere Treffer
3
R. J. S. D. Heine, F. W. Thielen, R. H. J. Mathijssen, R. W. F. van Leeuwen, M. G. Franken, C. A. Uyl-de Groot
2024
2024
Volltext
Weitere Treffer
Suche einschränken
Suchfilter entfernen
Filter aufheben
Schlagwörter: Plant Biology
Filter aufheben
Schlagwörter: Science Policy
Filter aufheben
Schlagwörter: based prices
Filter aufheben
Schlagwörter: pembrolizumab per vial
Filter aufheben
Dokumenttyp: Dataset
Filter aufheben
Online-Ressourcen: Volltexte online zugänglich
Filter aufheben
Datenquelle: BASE - Bielefeld Academic Search Engine
&# 8364
24
>
24
> expanding
24
Biotechnology
24
Cancer
24
Computational Biology
24
Ecology
24
Infectious Diseases
24
Plant Biology
Science Policy
already approved immuno
24
assumed lower r
24
based prices
based pricing
24
based pricing model
24
based pricing models
24
consistently lower
24
cumulative indication
24
daratumumab &# 8217
24
daratumumab </ p
24
daratumumab per vial
24
deterministic stepwise analysis
24
dutch list prices
24
eligible patient population
24
indication (&# 8364
24
indication broadening
24
indication expansion
24
indications due
24
initial r
24
initial years
24
l &# 246
24
larger patient populations
24
lower estimates resulted
24
model proposed
24
modeled cbps depending
24
ongoing discussions
24
pembrolizumab (&# 8364
24
pembrolizumab per vial
pharmaceutical pricing
24
potential effect
24
profit margin
24
profit margin contributed
24
registered indications
24
scenario analysis
24
sensitivity analysis showed
24
significant impact
24
significant influence
24
smaller patient populations
24
study focuses
24
xlink \
24